Fox Chase Cancer Center News

PHILADELPHIA (December 15, 2015) – Protein kinases play important roles in a range of cellular processes and have been implicated in diverse diseases, from cancer to obesity. Most of these proteins regulate their own activity through a biochemical process called autophosphorylation. Capturing snapshots of this event as it unfolds could be the key to understanding the molecular origins of disease and to developing a new generation of therapies.

PHILADELPHIA/ABU DHABI – (December 10, 2015) – Universal Hospital, one of Abu Dhabi’s leading health care providers, has signed a memorandum of understanding with Philadelphia-based Fox Chase Cancer Center—Temple Health to discuss establishing a world-class cancer center in the United Arab Emirates. The proposed plan would initially establish a bone marrow transplant (BMT) program followed by the first comprehensive cancer center in the private sector in the United Arab Emirates.

PHILADELPHIA (December 10, 2015) – A delay after diagnosis  was found to be associated with lower overall and disease-specific survival rates, according to research published in JAMA Oncology.

PHILADELPHIA (December 7, 2015) – The combination of an epigenetic agent with arsenic trioxide may be a potential treatment for patients diagnosed with advanced myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) who cannot undergo intense chemotherapy. Fox Chase Cancer Center – Temple Health researchers presented the results of a phase 2 trial at the 2015 American Society of Hematology Annual Meeting in December 2015.

SAN ANTONIO (DECEMBER 7, 2015) – Researchers from Caris Life Sciences^® and Fox Chase Cancer Center – Temple Health announced the presentation of two studies revealing the potential for exploring new therapeutic options for triple-negative breast cancer (TNBC) at the 2015 San Antonio Breast Cancer Symposium (SABCS).

Temple Health educators are working to disseminate colorectal cancer information tailored to the needs of underserved Latino populations, as part of the National Cancer Institute’s (NCI) Center to Reduce Cancer Health Disparities (CRCHD), National Outreach Network (NON).

PHILADELPHIA (November 6, 2015) – Temple University Hospital earned the status of a “Blue Distinction Center for Transplants” by Blue Cross Blue Shield, in recognition of the Fox Chase-Temple University Hospital Bone Marrow Transplant (BMT) Program’s expertise in performing adult bone marrow transplants.

PHILADELPHIA (November 6, 2015) – A recent preclinical investigation of a novel small molecule called ONC201 suggests it could potentially offer therapeutic benefits for patients diagnosed with either triple negative or non-triple negative breast cancer. Researchers at Fox Chase Cancer Center – Temple Health presented these findings at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston from Nov. 5-9, 2015.